These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1458660)

  • 21. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
    Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F
    J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.
    Zhang J; Lu S; Huang H; Li X; Cai W; Ma J; Xi L
    Lasers Med Sci; 2016 Sep; 31(7):1391-6. PubMed ID: 27339057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
    Sidou F; Soto P
    Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
    McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
    Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective.
    Schaller M; Braunsdorf C; Mailänder-Sanchez D; Jäckel A; Müller J; Borelli C
    Mycoses; 2015 Oct; 58(10):632-6. PubMed ID: 26393437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.
    Shimamura T; Kubota N; Nagasaka S; Suzuki T; Mukai H; Shibuya K
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3150-5. PubMed ID: 21555762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly.
    Lauharanta J
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():41-3. PubMed ID: 1458664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a fractional 2940-nm Er:YAG laser and 5% amorolfine lacquer combination therapy versus a 5% amorolfine lacquer monotherapy for the treatment of onychomycosis: a randomized controlled trial.
    Zhang J; Zhang Y; Qin J; Lu S; Cai W; Li J; Huang H; Yang S; Xi L
    Lasers Med Sci; 2021 Feb; 36(1):147-152. PubMed ID: 32557000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo nail infection as an effective preclinical method for screening of new topical antifungals.
    Quatrin PM; Kaminski TFA; Berlitz SJ; Guerreiro ICK; Canto RFS; Fuentefria AM
    J Mycol Med; 2020 Jun; 30(2):100938. PubMed ID: 32111505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical avulsion with urea nail lacquer.
    Baran R; Tosti A
    J Dermatolog Treat; 2002 Dec; 13(4):161-4. PubMed ID: 19753735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into the effect of amorolfine nail lacquer.
    Flagothier C; Piérard-Franchimont C; Piérard GE
    Mycoses; 2005 Mar; 48(2):91-4. PubMed ID: 15743424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.
    Dehari D; Mehata AK; Priya V; Parbat D; Kumar D; Srivastava AK; Singh S; Agrawal AK
    AAPS PharmSciTech; 2022 Jun; 23(6):175. PubMed ID: 35750993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK
    Cutis; 2001 Aug; 68(2 Suppl):13-6. PubMed ID: 11665723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation.
    Thatai P; Sapra B
    Ther Deliv; 2018 Feb; 9(2):99-119. PubMed ID: 29325509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.